What if a blood test could detect the recurrence of childhood leukemia before current tests are able to identify it?
That is the promise at the heart of a new study conducted in the laboratory of Assis. Prof. Yosi Maruvka at our Faculty, in collaboration with Schneider Children’s Medical Center of Israel. Together, the researchers developed a highly sensitive method for detecting tiny traces of the disease that may go unnoticed by conventional tests.
The method searches for the unique genetic “fingerprint” of leukemia cells, potentially allowing physicians to identify children at risk of relapse at an earlier stage – or, as Dr. Maruvka describes it, to “find the needle in the haystack.”
This is exactly the kind of connection that inspires us – science, technology, and medicine coming together in groundbreaking research with the potential to make a real difference in children’s health and lives.
We are especially proud of Assis. Prof. Maruvka and of our alumna Dana Dayan, one of the study’s lead authors. Dana completed her MSc in Maruvka’s laboratory and is now pursuing her PhD at Yale University.
Congratulations to Yossi, Dana, and the entire research team on this promising work.
Read the full story:
https://healthy.walla.co.il/item/3860444
Read the published study:
https://onlinelibrary.wiley.com/doi/full/10.1002/hem3.70424
